Literature DB >> 14725612

The citrus-derived flavonoid naringenin exerts uterotrophic effects in female mice at human relevant doses.

Vibeke Miller Breinholt1, Gitte Winkel Svendsen, Lars Ove Dragsted, Alireza Hossaini.   

Abstract

Gavage administration of the citrus flavonoid naringenin, 3',4,5,7-tetrahydroxyflavanon for 4 consecutive days, to immature female mice (postnatal day 17-20) at 4 or 100 mg/kg b.wt. significantly increased uterine weights 3 and 4 times, respectively. Analysis of uterine oestrogen receptor alpha revealed that naringenin significantly increased the cytosolic concentration of oestrogen receptor alpha, whereas in nuclei the oestrogen receptor alpha concentration was significantly decreased as compared to the solvent control. This was in contrast to the positive control 17 beta-oestradiolacetate which acted as a true oestrogen by increasing the concentration of both total and nuclear oestrogen receptor alpha. Both naringenin and 17 beta-oestradiolacetate, however, significantly, induced nuclear oestrogen receptor alpha in the liver, suggesting a tissue specific effect of naringenin on oestrogen receptor alpha distribution. In order to investigate the tissue levels at which the uterotrophic effect was observed, the distribution of an oral dose of tritiated naringenin (4 mg/kg) was investigated in 3-week-old female mice. The radioactivity content (ng naringenin equivalents/g tissue) was found to be highest in the gastrointestinal-tract, followed by the kidneys and liver. Uterus and ovaries were also found to contain relatively high and approximately equal amounts of naringenin. The concentration of naringenin in uterus and ovaries was found to be ten times higher as compared to the mammary tissue. The urinary excretion of more than 25% of the administered dose, within 8 hr after dosing indicated that naringenin is absorbed extensively in mice. The plasma concentration of 0.5 microM found in the present study is similar to the peak plasma concentration of naringenin (0.6 microM) observed in man following ingestion of 400-760 ml of orange juice (Erlund et al. 2001). This could be taken to suggests that ingestion of orange juice and other citrus fruits and juices may give rise to sufficiently high tissue levels of naringenin in man to exert a biological effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14725612

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  6 in total

1.  Efficacy of naringenin against permethrin-induced testicular toxicity in rats.

Authors:  Heba El-Sayed Mostafa; Samia A Abd El-Baset; Asmaa A A Kattaia; Rania A Zidan; Mona M A Al Sadek
Journal:  Int J Exp Pathol       Date:  2016-02-12       Impact factor: 1.925

2.  The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus.

Authors:  Allan Henrique Depieri Cataneo; Diogo Kuczera; Andrea Cristine Koishi; Camila Zanluca; Guilherme Ferreira Silveira; Thais Bonato de Arruda; Andréia Akemi Suzukawa; Leandro Oliveira Bortot; Marcelo Dias-Baruffi; Waldiceu Aparecido Verri; Anny Waloski Robert; Marco Augusto Stimamiglio; Claudia Nunes Duarte Dos Santos; Pryscilla Fanini Wowk; Juliano Bordignon
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

3.  Therapeutic Potential of Naringenin Nanosuspension: In Vitro and In Vivo Anti-Osteoporotic Studies.

Authors:  Sonia Gera; Sunitha Sampathi; Sravya Maddukuri; Sujatha Dodoala; Vijayabhaskarreddy Junnuthula; Sathish Dyawanapelly
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

4.  Naringenin accords hepatoprotection from streptozotocin induced diabetes in vivo by modulating mitochondrial dysfunction and apoptotic signaling cascade.

Authors:  Radhika Kapoor; Poonam Kakkar
Journal:  Toxicol Rep       Date:  2014-08-13

5.  Perspective: The Potential Effects of Naringenin in COVID-19.

Authors:  Ricardo Wesley Alberca; Franciane Mouradian Emidio Teixeira; Danielle Rosa Beserra; Emily Araujo de Oliveira; Milena Mary de Souza Andrade; Anna Julia Pietrobon; Maria Notomi Sato
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

6.  Antioxidative and Anti-Inflammatory Activities of Chrysin and Naringenin in a Drug-Induced Bone Loss Model in Rats.

Authors:  Nada Oršolić; Johann Nemrava; Željko Jeleč; Marina Kukolj; Dyana Odeh; Boris Jakopović; Maja Jazvinšćak Jembrek; Tomica Bagatin; Rajko Fureš; Dinko Bagatin
Journal:  Int J Mol Sci       Date:  2022-03-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.